MSL
TWST icon

Mackay Shields LLC’s Twist Bioscience TWST Stock Holding History

Mackay Shields LLC’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,500
Closed -$1.55M – 1291
2021
Q1 		$1.55M Sell
12,500
-8,400
-40% -$1.28M 0.01% 865
2020
Q4 		$2.95M Sell
20,900
-3,300
-14% -$366K 0.02% 676
2020
Q3 		$1.84M Buy
+24,200
New +$1.51M 0.01% 822

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mackay Shields LLC's TWST Position: Q2 2021 in Review

Mackay Shields LLC sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 12,500 shares — an estimated $1.55M sold.

Mackay Shields LLC first reported a position in TWST in Q3 2020 and held it in 3 quarters. The position peaked at $2.95M in Q4 2020. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

  • Mackay Shields LLC reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 12,500 Twist Bioscience shares in Q2 2021, an estimated $1.55M.
  • Mackay Shields LLC first reported a position in Twist Bioscience in Q3 2020 and held it in 3 quarters.
  • Mackay Shields LLC's Twist Bioscience position peaked at $2.95M in Q4 2020.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.